mRNA vaccines for cancer immunotherapy
Immunotherapy has emerged as a breakthrough strategy in cancer treatment. mRNA vaccines are an attractive and powerful immunotherapeutic platform against cancer because of their high potency, specificity, versatility, rapid and large-scale development capability, low-cost manufacturing potential, an...
Main Authors: | Yashavantha L. Vishweshwaraiah, Nikolay V. Dokholyan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1029069/full |
Similar Items
-
Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
by: Basmah N. Aldosari, et al.
Published: (2021-02-01) -
Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy
by: Hong-Li Wang, et al.
Published: (2022-08-01) -
Advancing mRNA technologies for therapies and vaccines: An African context
by: Dylan Kairuz, et al.
Published: (2022-10-01) -
A Comprehensive Review of mRNA Vaccines
by: Vrinda Gote, et al.
Published: (2023-01-01) -
mRNA vaccines in the prevention and treatment of diseases
by: Yangzhuo Gu, et al.
Published: (2022-09-01)